| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1010021729 |
| P356 | DOI | 10.1038/NM0898-963 |
| P698 | PubMed publication ID | 9701252 |
| P50 | author | Emmanuel Brouillet | Q42839922 |
| P2093 | author name string | Condé F | |
| Hantraye P | |||
| Palfi S | |||
| Peschanski M | |||
| Riche D | |||
| Chibois A | |||
| Dautry C | |||
| Mittoux V | |||
| P2860 | cites work | Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates | Q34103541 |
| Graft-induced behavioral recovery in an animal model of Huntington disease | Q35601129 | ||
| Intrastriatal transplantation of cross-species fetal striatal cells reduces abnormal movements in a primate model of Huntington disease | Q37600345 | ||
| Comparison of the Neuropsychological Deficits Associated With Early and Advanced Huntington's Disease | Q39859862 | ||
| Rationale for intrastriatal grafting of striatal neuroblasts in patients with Huntington's disease | Q40369954 | ||
| A primate model of Huntington's disease: behavioral and anatomical studies of unilateral excitotoxic lesions of the caudate-putamen in the baboon | Q41197259 | ||
| Selective putaminal excitotoxic lesions in non-human primates model the movement disorder of Huntington disease. | Q42279258 | ||
| Monitoring of cell viability in suspensions of embryonic CNS tissue and its use as a criterion for intracerebral graft survival | Q42435290 | ||
| Increased proportion of acetylcholinesterase-rich zones and improved morphological integration in host striatum of fetal grafts derived from the lateral but not the medial ganglionic eminence. | Q42491088 | ||
| Ontogeny of human striatal DARPP-32 neurons in fetuses and following xenografting to the adult rat brain | Q45291607 | ||
| Chronic 3-nitropropionic acid treatment in baboons replicates the cognitive and motor deficits of Huntington's disease | Q45291813 | ||
| Differential cognitive impairment in Alzheimer's disease and Huntington's disease | Q45299007 | ||
| Successful performance by monkeys with lesions of the hippocampal formation on AB and object retrieval, two tasks that mark developmental changes in human infants | Q46302522 | ||
| Striatal graft-associated recovery of a lesion-induced performance deficit in the rat requires learning to use the transplant | Q48551710 | ||
| Enduring Cognitive Deficits and Cortical Dopamine Dysfunction in Monkeys After Long-Term Administration of Phencyclidine | Q48637204 | ||
| DARPP-32, a dopamine- and adenosine 3':5'-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. II. Purification and characterization of the phosphoprotein from bovine caudate nucleus | Q48691482 | ||
| A stereotaxic atlas of the brain of the cynomolgus monkey (Macaca fascicularis) | Q70325126 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Huntington's disease | Q190564 |
| striatum | Q1319792 | ||
| P304 | page(s) | 963-966 | |
| P577 | publication date | 1998-08-01 | |
| P1433 | published in | Nature medicine | Q1633234 |
| P1476 | title | Fetal striatal allografts reverse cognitive deficits in a primate model of Huntington disease | |
| P478 | volume | 4 |
| Q33921503 | Cell replacement therapies for central nervous system disorders. |
| Q22305670 | Cell therapy in Huntington disease |
| Q34360444 | Cellular and molecular aspects of striatal development |
| Q35648164 | Cellular therapy and induced neuronal replacement for Huntington's disease. |
| Q44300705 | Chronic ischemic stroke model in cynomolgus monkeys: behavioral, neuroimaging and anatomical study |
| Q35105749 | Clinical and Research Advances in Huntington's Disease |
| Q34307633 | Cognitive dysfunction and depression in Parkinson's disease: what can be learned from rodent models? |
| Q43115809 | Comparison of transplant efficiency between spontaneously derived and noggin-primed human embryonic stem cell neural precursors in the quinolinic acid rat model of Huntington's disease |
| Q24548047 | Cystamine and cysteamine increase brain levels of BDNF in Huntington disease via HSJ1b and transglutaminase |
| Q42488566 | Delayed onset of progressive dystonia following subacute 3-nitropropionic acid treatment in Cebus apella monkeys |
| Q36016932 | Development of novel therapies for Huntington's disease: hope and challenge |
| Q34608910 | Differentiation of pluripotent stem cells into striatal projection neurons: a pure MSN fate may not be sufficient |
| Q33994217 | Effect of fetal neural transplants in patients with Huntington's disease 6 years after surgery: a long-term follow-up study |
| Q45305166 | Expression of mutated huntingtin fragment in the putamen is sufficient to produce abnormal movement in non-human primates |
| Q73258578 | Fetal hippocampal grafts containing CA3 cells restore host hippocampal glutamate decarboxylase-positive interneuron numbers in a rat model of temporal lobe epilepsy |
| Q45301914 | First step towards cell therapy for Huntington's disease |
| Q64240481 | Human Pluripotent Stem Cell-Derived Striatal Interneurons: Differentiation and Maturation In Vitro and in the Rat Brain |
| Q30512860 | Human embryonic stem cell-derived GABA neurons correct locomotion deficits in quinolinic acid-lesioned mice. |
| Q42463574 | Human neural stem cell transplants improve motor function in a rat model of Huntington's disease |
| Q35648168 | Human pluripotent stem cell therapy for Huntington's disease: technical, immunological, and safety challenges human pluripotent stem cell therapy for Huntington's disease: technical, immunological, and safety challenges |
| Q73229472 | Impact of a preceding striatal excitotoxic lesion and treatment with ciliary neurotrophic factor on striatal graft survival |
| Q35096123 | Molecular pathways in cerebral ischemia: cues to novel therapeutic strategies. |
| Q45301920 | Motor and cognitive improvements in patients with Huntington's disease after neural transplantation |
| Q34120779 | Neural transplantation for the treatment of Huntington's disease |
| Q35214572 | Neural transplantation in patients with Huntington's disease |
| Q47687033 | Nonhuman Primate Models of Neurodegenerative Disorders |
| Q26859430 | Nonhuman Primate Models of Stroke for Translational Neuroprotection Research |
| Q35907626 | Novel therapies in the search for a cure for Huntington's disease |
| Q34623843 | Opinion: neural stem cell therapy for neurological diseases: dreams and reality |
| Q74154108 | Pattern of long-distance projections from fetal hippocampal field CA3 and CA1 cell grafts in lesioned CA3 of adult hippocampus follows intrinsic character of respective donor cells |
| Q39973294 | Primate adult brain cell autotransplantation, a pilot study in asymptomatic MPTP-treated monkeys |
| Q35597258 | Progressive cognitive deficit, motor impairment and striatal pathology in a transgenic Huntington disease monkey model from infancy to adulthood |
| Q59355563 | Promoting remyelination through cell transplantation therapies in a model of viral-induced neurodegenerative disease |
| Q45297193 | Prospectives for cell and gene therapy in Huntington's disease |
| Q38795457 | Protein regulation of induced pluripotent stem cells by transplanting in a Huntington's animal model |
| Q30698358 | Reverse transcription of inserted DNA in a monkey gives us ANDi. |
| Q36113038 | Stem cell therapy for central nervous system demyelinating disease |
| Q35844778 | Stem cell therapy for human neurodegenerative disorders-how to make it work |
| Q38055455 | Stem cell-based therapy for Huntington's disease |
| Q34120774 | Striatal tissue transplantation in non-human primates |
| Q42526865 | Subacute systemic 3-nitropropionic acid intoxication induces a distinct motor disorder in adult C57Bl/6 mice: behavioural and histopathological characterisation |
| Q44149889 | Survival of fetal hippocampal CA3 cell grafts in the middle-aged and aged hippocampus: effect of host age and deafferentation |
| Q35597607 | The Current Status of Neural Grafting in the Treatment of Huntington's Disease. A Review |
| Q44186014 | The adenosine A1 receptor agonist adenosine amine congener exerts a neuroprotective effect against the development of striatal lesions and motor impairments in the 3-nitropropionic acid model of neurotoxicity. |
| Q36525175 | The application of NMR-based metabonomics in neurological disorders |
| Q36045409 | The design of clinical trials for cell transplantation into the central nervous system |
| Q45299643 | The problem of antipsychotic treatment for functional imaging in Huntington's disease: receptor binding, gene expression and locomotor activity after sub-chronic administration and wash-out of haloperidol in the rat. |
| Q37868574 | Translating promising preclinical neuroprotective therapies to human stroke trials |
| Q45290606 | Transplantation of GABAergic Cells Derived from Bioreactor-Expanded Human Neural Precursor Cells Restores Motor and Cognitive Behavioral Deficits in a Rodent Model of Huntington's Disease |
| Q31118947 | Unilateral transplantation of human primary fetal tissue in four patients with Huntington's disease: NEST-UK safety report ISRCTN no 36485475. |
| Q77715091 | [Neuronal grafts: a successful connection between basic and clinical research] |
Search more.